Records containing: Leukemia, Myelocytic, Acute
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-04A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myeloproliferative Neoplasms)
-
CLINICAL_TRIALS study record update · 2023-09-15Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years
-
CLINICAL_TRIALS study record update · 2023-02-16A Phase I, Dose-finding Study of the Oral, Dual Phosphatidylinositol 3(PI3)-Kinase / Mammilian Target of Rapamycin (mTOR) Inhibitor BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia
-
CLINICAL_TRIALS study record update · 2019-05-01Randomized Trial of Unmanipulated Versus Expanded Cord Blood
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-10-31Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes for Therapy of Relapsed Leukemia After Allogeneic Stem Cell Therapy
-
CLINICAL_TRIALS study record update · 2018-05-30A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN #0901)
-
CLINICAL_TRIALS study record update · 2017-11-17AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10
-
CLINICAL_TRIALS study record update · 2017-03-10A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients
-
CLINICAL_TRIALS study record update · 2016-11-07ClinicalTrials.gov study NCT00000589
-
CLINICAL_TRIALS study record update · 2016-09-09A Clinical Trial of Donor-derived WT1 Specific T Cells for Prevention of Relapse in Combination With Multiple Pathogen Specific T Cells for Prevention of Infection in Patients Undergoing Allogeneic Haemopoietic Stem Cell Transplant for AML
-
CLINICAL_TRIALS study record update · 2016-03-07A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
-
CLINICAL_TRIALS study record update · 2015-09-25Phase II Study: HSCT Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
-
CLINICAL_TRIALS study record update · 2014-11-10A Phase 2 Single Arm Trial of HLA-Matched Transplants, CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated by CliniMACS System in the Treatment of Patients With AML in 1st or 2nd Morphologic Complete Remission (BMTCTN0303)
-
CLINICAL_TRIALS study record update · 2012-12-07A Phase II Study of Parathyroid Hormone Following Myeloablative Sequential Unrelated Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2012-11-08Risk Adapted Treatment for Primary AML in Adults, Based on Genetics and Minimal Residual Disease (MRD) in Patients up to the Age of 70 Years.
-
CLINICAL_TRIALS study record update · 2012-11-01Risk Adapted Treatment for Primary AML in Adults up to the Age of 60 Years.
-
CLINICAL_TRIALS study record update · 2012-01-26Use of the MiCK Assay for Apoptosis to Predict Complete Remission in Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2012-01-19A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-03-10Multicenter Study of 9-AC in Refractory Leukemia
-
CLINICAL_TRIALS study record update · 2010-07-27Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
-
CLINICAL_TRIALS study record update · 2010-03-26A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
-
CLINICAL_TRIALS study record update · 2010-02-02Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2009-08-20A Randomized Study of Two Doses Gemtuzumab Ozogamicin vs. A Two-year Maintenance With Atra Plus Chemotherapy as Post-consolidation Treatment for Intermediate and High-risk Adult Patients With Acute Promyelocytic Leukemia (Apl)
-
CLINICAL_TRIALS study record update · 2009-07-29A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML)